1-11 of 11
J Janssen
Close
Sort by
Journal Articles

EP0042, a Dual FLT3 and Aurora Kinase Inhibitor: Preliminary Results of an Ongoing Phase I/IIa First in Human Study in Patients with Relapsed/Refractory Acute Myeloid Leukemia

David Taussig, Jenny O'Nions, Mojca Jongen-Lavrencic, Jeroen J. Janssen, David C. de Leeuw, Peter T. Tan, Sue Brook, Katie Stoddart, Hendrik-Tobias Arkenau, Geoff Fisher
Journal: Blood
Blood (2022) 140 (Supplement 1): 6222–6223.
https://doi.org/10.1182/blood-2022-166400
Published: 2022
Journal Articles

Allogeneic Hematopoietic Cell Transplantation Outcomes of Patients with R/R AML or Higher-Risk MDS Treated with the TIM-3 Inhibitor MBG453 (Sabatolimab) and Hypomethylating Agents

Andrew M. Brunner, Elie Traer, Norbert Vey, Sebastian Scholl, Natalia Tovar, Kimmo Porkka, Rupa Narayan, Guillermo Garcia-Manero, Steve Knapper, Martin Wermke, Jeroen J. Janssen, Jordi Esteve, Sun Loo, Mika Kontro, Zachariah Defilipp, Andrew H. Wei, Uma Borate
Journal: Blood
Blood (2021) 138 (Supplement 1): 3677.
https://doi.org/10.1182/blood-2021-151455
Published: 2021
Journal Articles

Effects of Food on the Pharmacokinetics of Nilotinib in Chronic Myeloid Leukemia: Enabling Significant Dose Reduction and Relief of Treatment Burden: The NIFO-Study

Christel C. Boons, MSc, Yvonne den Hartog, Jeroen J. Janssen, MD PhD, Anthe S. Zandvliet, PharmD, PhD, René Vos, Eleonora L. Swart, PharmD, PhD, N. Harry Hendrikse, PharmD, PhD, Jacqueline G. Hugtenburg, PharmD, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1736.
https://doi.org/10.1182/blood-2018-99-118149
Published: 2018
Journal Articles

International, Prospective Study Comparing Nilotinib Versus Imatinib with Early Switch to Nilotinib to Obtain Sustained Treatment-Free Remission in Patients with Chronic Myeloid Leukemia. a GIMEMA and HOVON Study

Fabrizio Pane, Luigia Luciano, MD, Novella Pugliese, MD, Juan Luis Steegman, Prof, Peter E. Westerweel, MD, Elisabetta Abruzzese, MD, Massimo Breccia, MD, Monica Bocchia, MD PhD, Simona Soverini, PhD, Fausto Castagnetti, MD PhD, Maria Monteverde, Gianantonio Rosti, Giuseppe Saglio, Jeroen J. Janssen, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1750.
https://doi.org/10.1182/blood-2018-99-118925
Published: 2018
Journal Articles

Efficacy of Bone Marrow Derived MSC for Steroid Refractory Acute GVHD Associates with Age and a Defined Molecular Profile of MSC Donors

Lotte van der Wagen, MD, Febilla Fernando, Nagesha Appukudige, PhD, Anke Janssen, MD, Kasper Westinga, Rick Admiraal, MD PhD, Magdalena Lorenowicz, PhD, Paul J. Coffer, PhD Prof, Sacha Zeerleder, PhDMD, Jeroen J. Janssen, MD PhD, Gerwin Huls, MD PhD, Annoek Broers, MD PhD, Walter JFM Van Der Velden, Marinus van Marwijk Kooij, MD PhD, Jaap Jan Boelens, MD PhD, Ineke Slaper-Cortenbach, PhD, Jurgen Kuball, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1929.
https://doi.org/10.1182/blood.V130.Suppl_1.1929.1929
Published: 2017
Journal Articles

Donor versus no-donor comparison of newly diagnosed myeloma patients included in the HOVON-50 multiple myeloma study

CME
Henk M. Lokhorst, Bronno van der Holt, Jan J. Cornelissen, Marie-José Kersten, Marinus van Oers, Reinier Raymakers, Monique C. Minnema, Sonja Zweegman, Jeroen J. Janssen, Mark Zijlmans, Gerard Bos, Nicolaas Schaap, Shulamiet Wittebol, Okke de Weerdt, Rianne Ammerlaan, Pieter Sonneveld
Journal: Blood
Blood (2012) 119 (26): 6219–6225.
https://doi.org/10.1182/blood-2011-11-393801
Published: 2012
Journal Articles

Lenalidomide maintenance after nonmyeloablative allogeneic stem cell transplantation in multiple myeloma is not feasible: results of the HOVON 76 Trial

Clinical Trials & Observations
Evelien Kneppers, Bronno van der Holt, Marie-Jose Kersten, Sonja Zweegman, Ellen Meijer, Gerwin Huls, Jan J. Cornelissen, Jeroen J. Janssen, Cynthia Huisman, Petra B. Cornelisse, Cheryl P. Bruijnen, Maarten Emmelot, Pieter Sonneveld, Henk M. Lokhorst, Tuna Mutis, Monique C. Minnema
Journal: Blood
Blood (2011) 118 (9): 2413–2419.
https://doi.org/10.1182/blood-2011-04-348292
Published: 2011
Journal Articles

The CD40-TRAF6 axis is the key regulator of the CD40/CD40L system in neointima formation and arterial remodeling

Marjo M. P. C. Donners, Linda Beckers, Dirk Lievens, Imke Munnix, Johan Heemskerk, Ben J. Janssen, Erwin Wijnands, Jack Cleutjens, Alma Zernecke, Christian Weber, Cory L. Ahonen, Ulrike Benbow, Andrew C. Newby, Randolph J. Noelle, Mat J. A. P. Daemen, Esther Lutgens
Journal: Blood
Blood (2008) 111 (9): 4596–4604.
https://doi.org/10.1182/blood-2007-05-088906
Published: 2008
Includes: Supplemental data
Journal Articles

Economic Evaluation of Posaconazole Versus Standard Azole Prophylaxis in High Risk Neutropenic Patients in The Netherlands.

Wiro B. Stam, PhD, Amy K. O’Sullivan, PhD, Bart Rijnders, MD, PhD, Elly Lugtenburg, MD, PhD, Lambert F. Span, MD, PhD, Jeroen J. Janssen, MD, Jeroen P. Jansen, PhD
Journal: Blood
Blood (2007) 110 (11): 3335.
https://doi.org/10.1182/blood.V110.11.3335.3335
Published: 2007
Journal Articles

Identification of Genes Potentially Involved in Disease Transformation of CML.

Jeroen J. Janssen, MD, S. Marjolein Klaver, Msc, Quinten Waisfisz, PhD, Gerard Pasterkamp, MD, PhD, Dominique P. de Kleijn, MD, PhD, Gerrit J. Schuurhuis, PhD, Gerrit J. Ossenkoppele, MD, PhD
Journal: Blood
Blood (2004) 104 (11): 2950.
https://doi.org/10.1182/blood.V104.11.2950.2950
Published: 2004
Journal Articles

Depletion of donor lymphocytes by counterflow centrifugation successfully prevents acute graft-versus-host disease in matched allogeneic marrow transplantation

T de Witte, J Hoogenhout, B de Pauw, R Holdrinet, J Janssen, J Wessels, W van Daal, T Hustinx, C Haanen
Journal: Blood
Blood (1986) 67 (5): 1302–1308.
https://doi.org/10.1182/blood.V67.5.1302.1302
Published: 1986